Mene ne Ƙananan CD4 Count da CD4 Rabin?

Bayyana gwaje-gwaje na jini yana taimakawa wajen hango hangen nesa

Daidaran tantanin CD4 T4 yana da muhimmanci wajen taimaka wa likitoci da ƙayyade mataki da kuma yiwuwar sakamakon cutar HIV. Duk da yake ba'a amfani da su ba don ƙayyade lokacin da za'a fara farfutar HIV - maganin ya kamata a fara koyaushe a lokacin ganewar asali - sun iya ba likitoci damar zama na ainihi game da yadda mutumin yake da kuma abin da za a iya yi don inganta zamanta na tsawon lokaci kiwon lafiya.

Fahimtar CD4 da CD8 T-Cells

Da farko, lymphocytes sune nau'i na jini mai tsabta wanda zai taimaka wa jiki yayi fama da kamuwa da cuta. Akwai nau'o'in lymphocytes guda biyu: B-lymphocytes da T-lymphocytes. Daga cikin waɗannan, akwai nau'o'i biyu na T da muke saka idanu a yayin da ake dauke da cutar HIV:

Darajar Mafi kyawun CD4 Count

Ƙididdigar CD4 cikakke shine ƙididdiga na yawan CD4 T-cell ke aiki a cikin jini. Ƙananan ƙididdigar CD4, ƙarƙashin maɓallin amsawa.

Ana kiyasta ƙididdigar CD4 cikakkar ta hanyar gwajin jini mai sauƙi, wanda aka fitar da sakamakonsa kamar adadin ƙwayoyin CD4 a cikin millimeter na jini. Kwayoyin cutar HIV da yawa suna da cikakken CD4 masu la'akari da kwayoyin CD4 600 da 1200 a kowace millimeter. Ya bambanta, mutanen da ke fama da kwayar cutar HIV sun ƙidaya cewa yawanci kasa da 500, dangane da mataki na kamuwa da cuta, yayin da mutane da ke da ciwon HIV sun iya samun nau'in T-CD4 ko žasa a cikin millimita.

Ƙididdigar CD4 cikakke an dauke shi mafi kyawun kayan aiki wanda zai iya hango hatsarin ci gaban HIV.

Abin da kashi na CD4 ya faɗa mana

Matsayin CD4 yana wakiltar yawan yawan kwayoyin lymphocytes wadanda suke da CD4 kuma an auna ta ta yin amfani da wannan gwajin jini kamar wancan don ƙimar CD4 cikakke.

Yawanci, masu cutar HIV za su sami kashi CD4 na kimanin kashi 40, yayin da CD4 na kamuwa da kwayar cutar HIV na iya zama low as 25 bisa dari ko žasa. A bayyane yake, mafi girman girman, yawancin karfin da aka samu.

Idan ƙididdigar CD4 ya fi ƙasa da yadda kuke tsammani, kashi CD4 zai iya sa shi cikin mafi kyau ta hanyar gaya mana ko wannan ainihin canji ne ko kuma haɓaka kawai.

CD4 / CD8 Rataya a matsayin Hoton Rashin Lafiya

Ɗaya daga cikin hanyoyin da za a samu mafi kyau game da aikin mai yaduwar cuta shine a ƙara nazarin kashi CD4 / CD8 na mai haƙuri , wanda yayi nazari yawan adadin T-CD4 da aka kwatanta da yawan CD-T-cell. Tare da gwaji, zamu ga idan cutar ta ci gaba ta hanyar gano lalata "Tiller" T a cikin samfurori na jini.

Yawanci, a ci gaba da cutar, yayin da tsarin rigakafi ya ƙare , ba shi da ikon samar da kwayoyin T don kare kansa. Matsayin CD4 / CD8 yana taimaka mana mu ga wannan.

A cikin 'yan shekarun nan, an sanya muhimmancin girmamawa a kan CD4 / CD8 a cikin yawan tsufa na cutar HIV . Binciken binciken likita na kwanan nan ya nuna cewa marasa lafiya a tasiri, dogon lokaci ART tare da raƙuman CD4 / CD8 suna da haɗari ga rashin lafiyar mutum da cutar ta HIV.

Me yasa wadannan gwaje-gwaje na da muhimmanci

Kwanan adadin CD4 da CD4 ya ba likitan ku hoto na lafiyar lafiyar ku, da kuma alamar cutarku na ci gaba.

A cikin mafi sauki, mun san cewa CD4 tana ƙididdigar ƙasa da 200 inda mutumin da ke dauke da kwayar cutar HIV yana fuskantar hadarin cututtuka . Yawan kashi CD4, a halin yanzu, yana la'akari da yawan adadin lymphocytes kuma yana da karin haske game da lafiyar mutumin da na dadewa.

Idan, alal misali, ƙididdigar CD4 ya fi girma ne kawai saboda yawan ƙwayar lymphocyte ya fi girma, har yanzu muna da damuwa game da lafiyar marasa lafiya. Idan, a gefe guda, CD4 ƙananan saboda sakamakon ƙananan lymphocyte mai ƙananan, zamu fassara fassarar daban.

> Source:

> Gompels, M. Dunn, D .; Phillips, A ;; et al. "Shin rashin daidaito tsakanin CD4 Count da CD4 Kashi a cikin HIV-Positive Mutane Kowane Ɗaukaka Hanyoyin Sakamako a kan Matsalar Harkokin Kwayar cuta?" J Infect Dis. 2012; 205 (4): 540-547.

> Sauter, R; Huang, R .; Ledergerber, B; et al. "Rarraba CD4 / CD8 da CD8 sunyi la'akari da amsa CD4 a cikin kwayar cutar miyagun ƙwayoyi HIV-1 da kuma marasa lafiya a kan cART." Magunguna. 2016; 95 (42): e5094.